Globus Medical, Inc. (GMED)Healthcare | Medical Devices | Audubon, United States | NYSE
76.32 USD
+0.08
(0.105%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 76.32 |
Hot Take ↕ | Oct. 10, 2026, 3:03 a.m. EDT
Globus Medical presents a compelling value case with a fortress-like balance sheet—current assets dwarf liabilities, debt is manageable, and free cash flow remains robust. The market appears to be pricing in a temporary stumble, reflected in the 5.9% revenue growth and negative earnings growth, yet the forward P/E of roughly 14x suggests analysts see a turnaround. The disconnect between the strong fundamentals and the depressed price creates a solid medium-term setup, though the lack of a dividend and recent earnings miss keep the immediate outlook cautious. The options market confirms this tension: while there is a bullish bias targeting the $100 psychological level, the heavy put volume acts as a safety net, implying investors expect a bumpy road ahead rather than a straight line up. Until earnings growth turns positive, the stock will likely trade as a speculative value play rather than a momentum leader. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.050731 |
| AutoARIMA | 0.050731 |
| MSTL | 0.051483 |
| AutoTheta | 0.052144 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 3.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.140 |
| Excess Kurtosis | -1.44 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.347 |
| Revenue per Share | 23.325 |
| Market Cap | 10,246,870,016 |
| Trailing P/E | 19.57 |
| Forward P/E | 14.14 |
| Beta | 0.96 |
| Profit Margins | 17.03% |
| Website | https://www.globusmedical.com |
As of Oct. 10, 2026, 3:03 a.m. EDT: Speculators are positioning for a volatile range-bound outcome rather than a decisive directional move. Call open interest is heavily skewed out-of-the-money (OTM), with massive walls at strikes like $80, $95, and $100, suggesting bets on a rally toward $100+. However, put volume and open interest are significantly higher than calls, particularly in the near-to-medium term (Dec '26 and Mar '27), with heavy concentration at strikes $65-$82. This indicates a 'straddle' or 'strangle' bias where traders expect significant movement but are hedged against a drop below the current price, anticipating a choppy recovery rather than a breakout.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.31244624 |
| Address1 | 2,560 General Armistead Avenue |
| All Time High | 101.4 |
| All Time Low | 10.26 |
| Ask | 77.87 |
| Ask Size | 200 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.9 - Buy |
| Average Daily Volume10 Day | 1,529,440 |
| Average Daily Volume3 Month | 1,484,212 |
| Average Volume | 1,484,212 |
| Average Volume10Days | 1,529,440 |
| Beta | 0.959 |
| Bid | 74.99 |
| Bid Size | 100 |
| Board Risk | 9 |
| Book Value | 35.52 |
| City | Audubon |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 76.32 |
| Current Ratio | 4.622 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 76.71 |
| Day Low | 74.985 |
| Debt To Equity | 2.347 |
| Display Name | Globus Medical |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,908,800 |
| Earnings Call Timestamp Start | 1,793,908,800 |
| Earnings Growth | -0.262 |
| Earnings Quarterly Growth | -0.253 |
| Earnings Timestamp | 1,793,908,800 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 1,010,294,976 |
| Ebitda Margins | 0.32125 |
| Enterprise To Ebitda | 9.664 |
| Enterprise To Revenue | 3.105 |
| Enterprise Value | 9,763,639,296 |
| Eps Current Year | 5.0004 |
| Eps Forward | 5.39819 |
| Eps Trailing Twelve Months | 3.9 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 79.053 |
| Fifty Day Average Change | -2.7330017 |
| Fifty Day Average Change Percent | -0.034571763 |
| Fifty Two Week Change Percent | 31.244623 |
| Fifty Two Week High | 101.4 |
| Fifty Two Week High Change | -25.080002 |
| Fifty Two Week High Change Percent | -0.2473373 |
| Fifty Two Week Low | 56.96 |
| Fifty Two Week Low Change | 19.36 |
| Fifty Two Week Low Change Percent | 0.33988765 |
| Fifty Two Week Range | 56.96 - 101.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,344,000,600,000 |
| Float Shares | 110,900,341 |
| Forward Eps | 5.39819 |
| Forward P E | 14.138072 |
| Free Cashflow | 554,194,880 |
| Full Exchange Name | NYSE |
| Full Time Employees | 6,000 |
| Fullday Change | 0.08000183 |
| Fullday Change Percent | 0.1049342 |
| Fullday Price | 76.32 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.68974996 |
| Gross Profits | 2,169,228,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0061299996 |
| Held Percent Institutions | 0.92283994 |
| Implied Shares Outstanding | 134,261,914 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. |
| Long Name | Globus Medical, Inc. |
| Market | us_market |
| Market Cap | 10,246,870,016 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_8793244 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 535,431,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,930,011,159 |
| Number Of Analyst Opinions | 13 |
| Open | 76.7 |
| Operating Cashflow | 910,387,008 |
| Operating Margins | 0.24755 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.49 |
| Phone | 610 930 1800 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 76.32 |
| Post Market Time | 1,791,934,204 |
| Previous Close | 76.24 |
| Price Eps Current Year | 15.262778 |
| Price Hint | 2 |
| Price To Book | 2.1486485 |
| Price To Sales Trailing12 Months | 3.2582147 |
| Profit Margins | 0.17025 |
| Quick Ratio | 2.784 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.86667 |
| Region | US |
| Regular Market Change | 0.0800018 |
| Regular Market Change Percent | 0.104934 |
| Regular Market Day High | 76.71 |
| Regular Market Day Low | 74.985 |
| Regular Market Day Range | 74.985 - 76.71 |
| Regular Market Open | 76.7 |
| Regular Market Previous Close | 76.24 |
| Regular Market Price | 76.32 |
| Regular Market Time | 1,791,921,602 |
| Regular Market Volume | 1,108,124 |
| Return On Assets | 0.08736 |
| Return On Equity | 0.118140005 |
| Revenue Growth | 0.059 |
| Revenue Per Share | 23.325 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 10 |
| Shares Outstanding | 111,831,817 |
| Shares Percent Shares Out | 0.062800005 |
| Shares Short | 8,437,114 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 6,620,718 |
| Short Name | Globus Medical, Inc. |
| Short Percent Of Float | 0.076 |
| Short Ratio | 5.5 |
| Source Interval | 15 |
| State | PA |
| Symbol | GMED |
| Target High Price | 125.0 |
| Target Low Price | 84.0 |
| Target Mean Price | 100.92308 |
| Target Median Price | 100.0 |
| Total Cash | 595,142,016 |
| Total Cash Per Share | 4.433 |
| Total Debt | 111,912,000 |
| Total Revenue | 3,144,933,888 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.9 |
| Trailing P E | 19.569231 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 84.2761 |
| Two Hundred Day Average Change | -7.9561005 |
| Two Hundred Day Average Change Percent | -0.09440518 |
| Type Disp | Equity |
| Volume | 1,108,124 |
| Website | https://www.globusmedical.com |
| Zip | 19,403-5214 |